磷脂酰胆碱市场、机会、成长动力、产业趋势分析与预测，2024-2032

Phosphatidylcholine Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月30日 | 出版商:

Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球磷脂酰胆碱市场在2023 年达到13 亿美元，2024 年至2032 年将以6% 的复合年增长率增长，这得益于消费者健康意识的提高、製药应用的进步以及膳食补充剂需求的不断增长。随着人们越来越重视自己的健康，他们寻求有效的补充剂来支持认知功能、肝臟健康和整体健康。此外，研究和技术的进步正在扩大磷脂酰胆碱在药物中的应用，并增强其治疗潜力。健康意识和创新应用的融合使磷脂酰胆碱成为不断发展的健康领域的关键成分。

磷脂酰胆碱产业根据来源、形式、应用和地区进行细分。

2023 年，大豆市场规模为 5.783 亿美元，在其广泛供应和成本效益的推动下，2024 年至 2032 年将以 6.5% 的复合年增长率增长。大豆磷脂酰胆碱因其在膳食补充剂和药品中的成熟应用而受到青睐，使其成为製造商的热门选择。随着注重健康的消费者越来越多地寻求价格实惠且有效的补充剂，对大豆製品的需求持续增长。此外，对非基因改造和无过敏原成分的日益重视进一步增强了大豆磷脂酰胆碱的吸引力，巩固了其在市场上的主导地位。

药品领域在各种治疗应用中发挥关键作用，其销售额于 2023 年扩大至 4.773 亿美元，2024 年至 2032 年复合年增长率为 6.8%。磷脂酰胆碱因其在针对肝臟健康、认知功能和细胞膜完整性的配方中的高纯度和有效性而得到认可。随着对创新药物输送系统的需求增加，磷脂酰胆碱提高生物利用度和稳定性的能力使其成为製药製造商的首选成分。此外，正在进行的研究和开发工作可能会扩大其应用，从而加强其在製药领域的突出地位。

北美磷脂酰胆碱产业在 2023 年累计达到 4.701 亿美元，在消费者对健康和保健日益重视的推动下，到 2032 年将以 6.5% 的复合年增长率增长。该地区强大的製药业推动了各种治疗应用（包括膳食补充剂和功能性食品）对高品质磷脂酰胆碱的需求。此外，人们越来越认识到该成分对肝臟健康和认知功能的益处，进一步提高了其受欢迎程度。凭藉支持清洁标籤产品的强大监管框架，北美仍然是磷脂酰胆碱市场整体成长的重要贡献者。

产业生态系统分析
- 主要製造商
- 经销商
- 全行业利润率
产业影响力
- 成长动力
- 市场挑战
- 市场机会
  - 新机会
  - 成长潜力分析
原料景观
- 製造趋势
- 技术演进
  - 永续製造
    - 绿色实践
    - 脱碳
- 原材料的可持续性
- 价格趋势（美元/吨），2021 - 2032
法规和市场影响
波特的分析
PESTEL分析

第 4 章：竞争格局

公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场规模与预测：按来源划分，2021-2032 年

主要趋势
大豆
向日葵
蛋黄
油菜籽
其他（芥末、棉籽）

第 6 章：市场规模与预测：按形式划分，2021-2032 年

主要趋势
液体
粉末
颗粒剂

第 7 章：市场规模与预测：按应用划分，2021-2032 年

主要趋势
药品
膳食补充剂
化妆品和个人护理
食品和饮料
其他（动物营养及工业应用）

第 8 章：市场规模与预测：按地区划分，2021-2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
MEA
- 沙乌地阿拉伯
- 阿联酋
- 南非
- MEA 的其余部分

第 9 章：公司简介

Amitex Agro Product Pvt. Ltd.
Creative Biolabs
Croda International Plc
Fengchen Group Co., Ltd
Lipoid GmbH
Merck KGaA
MITUSHI BIO PHARMA
Rajvi Enterprise
SimSon Pharma Limited

简介目录

Product Code: 11157

The Global Phosphatidylcholine Market garnered USD 1.3 billion in 2023 and will grow at 6% CAGR from 2024 to 2032, spurred by heightened consumer awareness of health and wellness coupled with advancements in pharmaceutical applications and a growing demand for dietary supplements. As individuals increasingly prioritize their health, they seek effective supplements that support cognitive function, liver health, and overall well-being. Moreover, advancements in research and technology are expanding the applications of phosphatidylcholine in pharmaceuticals, enhancing its therapeutic potential. This convergence of health consciousness and innovative applications positions phosphatidylcholine as a key ingredient in the evolving wellness landscape.

The phosphatidylcholine industry is segmented based on source, form, application, and region.

The soybean segment held USD 578.3 million in 2023 and will expand at a 6.5% CAGR during 2024-2032, driven by its widespread availability and cost-effectiveness. Soybean-derived phosphatidylcholine is favored for its established applications in dietary supplements and pharmaceuticals, making it a popular choice among manufacturers. As health-conscious consumers increasingly seek affordable and effective supplements, the demand for soybean-based products continues to rise. Besides, the growing emphasis on non-GMO and allergen-free ingredients further enhances the appeal of soybean phosphatidylcholine, solidifying its dominant position in the market.

The pharmaceuticals segment was expanded to USD 477.3 million in 2023 and gain a 6.8% CAGR from 2024 to 2032, fueled by its critical role in various therapeutic applications. Phosphatidylcholine is recognized for its high purity and effectiveness in formulations targeting liver health, cognitive function, and cell membrane integrity. As the demand for innovative drug delivery systems increases, phosphatidylcholine's ability to enhance bioavailability and stability makes it a preferred ingredient among pharmaceutical manufacturers. Also, ongoing research and development efforts are likely to expand its applications, reinforcing its prominence in the pharmaceutical segment.

North America phosphatidylcholine industry accumulated USD 470.1 million in 2023 and will grow at a 6.5% CAGR till 2032, fueled by a growing emphasis on health and wellness among consumers. The region's strong pharmaceutical sector drives demand for high-quality phosphatidylcholine in various therapeutic applications, including dietary supplements and functional foods. Additionally, increasing awareness of the ingredient's benefits for liver health and cognitive function further boosts its popularity. With a robust regulatory framework supporting clean-label products, North America remains a significant contributor to the overall growth of the phosphatidylcholine market.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Market challenges
- 3.2.3 Market opportunity
  - 3.2.3.1 New opportunities
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
  - 3.3.2.1 Sustainable manufacturing
    - 3.3.2.1.1 Green practices
    - 3.3.2.1.2 Decarbonization
- 3.3.3 Sustainability in raw materials
- 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
  - 3.3.4.1 North America
  - 3.3.4.2 Europe
  - 3.3.4.3 Asia Pacific
  - 3.3.4.4 Latin America
  - 3.3.4.5 Middle East and Africa
3.4 Regulations and market impact
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Company market share analysis
4.2 Competitive positioning matrix
4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

5.1 Key trends
5.2 Soybean
5.3 Sunflower
5.4 Egg Yolk
5.5 Rapeseed
5.6 Others (mustard and cottonseed)

Chapter 6 Market Size and Forecast, By Form, 2021-2032 (USD Million, Tons)

6.1 Key trends
6.2 Liquid
6.3 Powder
6.4 Granules

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

7.1 Key trends
7.2 Pharmaceuticals
7.3 Dietary supplements
7.4 Cosmetics and personal care
7.5 Food and beverages
7.6 Others (animal nutrition and industrial application)

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 South Africa
- 8.6.4 Rest of MEA